Harrow Health, Inc. (HROW)

Harrow Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-31.33	-24.41	-14.09	-18.48	-3.36	0.17
Depreciation & Amortization	12.84	12.34	3.67	2.4	2.74	2.66
Share-Based Compensation	18.23	15.7	7.97	5.75	2.78	1.79
Other Operating Activities	7.68	0.22	4.15	14.95	-3.26	-3.67
Operating Cash Flow	7.43	3.84	1.71	5.08	-1.1	0.95
Operating Cash Flow Growth	-	125.22%	-66.45%	-	-	38.28%
Capital Expenditures	-1.06	-1.46	-2.57	-1.79	-0.86	-1.47
Acquisitions	-20.6	-151.08	1	-26.64	0	0
Change in Investments	0	0	0	9.83	0	0
Other Investing Activities	-0.04	-0.02	-0.18	-0.08	-0.12	-0.37
Investing Cash Flow	-21.69	-152.55	-1.74	-18.69	-0.98	-1.83
Share Issuance / Repurchase	65.1	64.9	23.3	0.07	0	0.77
Debt Issued / Paid	11.97	74.64	31.72	55.11	1.46	-1.78
Other Financing Activities	-13.51	-13.01	-0.88	-3.7	-0.03	-
Financing Cash Flow	63.56	126.53	54.14	51.47	1.43	-1.01
Net Cash Flow	49.29	-22.19	54.1	37.87	-0.65	-1.89
Free Cash Flow	6.37	2.38	-0.86	3.3	-1.96	-0.52
Free Cash Flow Margin	4.59%	1.83%	-0.97%	4.55%	-4.01%	-1.01%
Free Cash Flow Per Share	0.18	0.07	-0.03	0.12	-0.08	-0.02

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).